SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiorenal-Metabolic Syndrome: Canadian Evidence, Mechanistic Complementarity, and Pharmacotherapeutic Strategies MOHAMED ABDELLATIF Review Article | Open access | 1 July 2026 | Vol. 1, Issue 1
Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy: Canadian Practice and the Transition to Model-Informed Precision Dosing Mohamed Abdellatif Review Article | Open access | 18 June 2026 | Vol. 1, Issue 1
Clinical Pharmacist Interventions for Medication Adherence and Glycemic Control in Type 2 Diabetes: Lessons From Canadian Health Systems Mohamed Abdellatif Review Article | Open access | 1 June 2026 | Vol. 1, Issue 1